Henry Schein, Inc. (HSIC) Presents At Baird Global Healthcare Conference 2025 Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Baird Global Healthcare Conference 2025 September 10, 2025 10:50 AM EDT Company Participants Stanley Bergman - Executive Chairman & CEO Andrea Albertini - Chief Ex...
Henry Schein Announces $750 Million Share Repurchase Plan
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced tod...
Henry Schein Medical Expands SolutionsHub with Colaborate
Full-Service Laboratory Management Firm Helps Elevate Clinical Lab Operations NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has exp...
Henry Schein falls after missing quarterly profit estimates
Henry Schein missed Wall Street estimates for second-quarter profit and maintained its annual forecast on Tuesday, due to softer demand for its dental products in the United States.
IntelePeer Joins Henry Schein One Academic Partner Program
DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, a leading, end-to-end conversational AI platform provider for Dental Service Organizations (DSOs), today announced that it is now an authorized integ...
Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein , arguing the dental and medical distributor needs to start searching fo...
Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits
Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.
HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.
Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - ...
Henry Schein (HSIC) Q3 Earnings Top Estimates
Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago.
Unlocking Q3 Potential of Henry Schein (HSIC): Exploring Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Henry Schein (HSIC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estima...
HSIC Gears Up for Q3 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive sales in both its businesses in the third quarter of 2024, along with a low pace of recovery from the cyber incident.
Why Henry Schein (HSIC) Could Beat Earnings Estimates Again
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Related Companies